Status:

COMPLETED

Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache

Lead Sponsor:

Diamond Headache Clinic

Collaborating Sponsors:

Merck Sharp & Dohme LLC

Conditions:

Migraine With Aura

Migraine Without Aura

Eligibility:

All Genders

18-65 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate the effect of rizatriptan, alone or combined with caffeine for treating acute attacks of migraine. Each subject will have 3 months to treat 3 acute migraine h...

Detailed Description

Oral Maxalt has an extensive record of providing relief of acute migraine headache with 2 hours in the vast majority of patients, especially when undertaken as an early intervention strategy. Caffeine...

Eligibility Criteria

Inclusion

  • Subject is 18-65 years of age
  • Diagnosis of migraine with or without aura
  • 1 year history of migraine with 1-6 migraine attacks per month in the the three months prior to screening
  • Medication for migraine prevention with a stable dose for at least 1 month prior to screening
  • Has successfully treated a migraine attack with a triptan medication

Exclusion

  • Confirmed or suspected ischemic heart disease
  • History of congenital heart disease
  • History of cerebrovascular disease, including stroke
  • History of ischemic abdominal disease
  • Uncontrolled hypertension
  • History of epilepsy
  • History of basilar or hemiplegic migraine
  • Impaired hepatic or renal function
  • Greater than 15 headache days per month
  • Subjects on an MAOI
  • Subjects taking and ergotamine, or ergot containing preventive medication
  • Subject is pregnant, trying to become pregnant or breast feeing
  • Evidence of alcohol or substance abuse in the last year
  • History of caffeine withdrawal headache
  • Consumes more than 275 mg of caffeine on daily basis from dietary and medication sources
  • Taking propanolol

Key Trial Info

Start Date :

April 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2008

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT00471952

Start Date

April 1 2007

End Date

April 1 2008

Last Update

April 25 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Diamond Headache Clinic

Chicago, Illinois, United States, 60614